RAPT logo

RAPT Therapeutics (RAPT) EBITDA

Annual EBITDA

-$125.85 M
-$41.10 M-48.49%

31 December 2023

RAPT EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBITDA

-$19.49 M
+$9.53 M+32.85%

30 September 2024

RAPT Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

-$113.61 M
+$14.10 M+11.04%

30 September 2024

RAPT TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

RAPT EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-48.5%+42.0%+3.0%
3 y3 years-141.6%-6.5%-79.7%
5 y5 years-252.4%-95.4%-189.9%

RAPT EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-141.6%at low-9.5%+42.0%-79.7%+11.0%
5 y5 years-252.4%at low-95.4%+42.0%-189.9%+11.0%
alltimeall time-350.3%at low-142.2%+42.0%-1311.2%+11.0%

RAPT Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Sept 2024
-
-$19.49 M(-32.8%)
-$113.61 M(-11.0%)
June 2024
-
-$29.02 M(-9.9%)
-$127.72 M(+0.7%)
Mar 2024
-
-$32.20 M(-2.1%)
-$126.79 M(+0.7%)
Dec 2023
-$125.85 M(+48.5%)
-$32.89 M(-2.1%)
-$125.85 M(+7.4%)
Sept 2023
-
-$33.59 M(+19.6%)
-$117.13 M(+11.6%)
June 2023
-
-$28.09 M(-10.1%)
-$104.95 M(+9.9%)
Mar 2023
-
-$31.26 M(+29.3%)
-$95.50 M(+12.7%)
Dec 2022
-$84.75 M(+24.2%)
-$24.18 M(+12.9%)
-$84.75 M(+8.1%)
Sept 2022
-
-$21.42 M(+14.9%)
-$78.37 M(+4.1%)
June 2022
-
-$18.64 M(-9.2%)
-$75.26 M(+3.9%)
Mar 2022
-
-$20.52 M(+15.2%)
-$72.45 M(+6.2%)
Dec 2021
-$68.21 M
-$17.80 M(-2.7%)
-$68.21 M(+7.9%)
Sept 2021
-
-$18.30 M(+15.7%)
-$63.23 M(+6.7%)
June 2021
-
-$15.82 M(-2.8%)
-$59.24 M(+6.7%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$16.28 M(+27.0%)
-$55.53 M(+6.6%)
Dec 2020
-$52.09 M(+23.1%)
-$12.82 M(-10.5%)
-$52.09 M(+0.6%)
Sept 2020
-
-$14.32 M(+18.2%)
-$51.77 M(+9.2%)
June 2020
-
-$12.12 M(-5.6%)
-$47.42 M(+3.3%)
Mar 2020
-
-$12.84 M(+2.7%)
-$45.93 M(+8.6%)
Dec 2019
-$42.30 M(+18.5%)
-$12.50 M(+25.3%)
-$42.30 M(+8.0%)
Sept 2019
-
-$9.97 M(-6.1%)
-$39.18 M(-0.7%)
June 2019
-
-$10.62 M(+15.3%)
-$39.45 M(+7.0%)
Mar 2019
-
-$9.21 M(-1.7%)
-$36.87 M(+3.3%)
Dec 2018
-$35.71 M(+27.8%)
-$9.38 M(-8.4%)
-$35.71 M(+35.6%)
Sept 2018
-
-$10.24 M(+27.2%)
-$26.33 M(+63.6%)
June 2018
-
-$8.05 M(-0.1%)
-$16.10 M(+99.9%)
Mar 2018
-
-$8.05 M
-$8.05 M
Dec 2017
-$27.95 M
-
-

FAQ

  • What is RAPT Therapeutics annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for RAPT Therapeutics?
  • What is RAPT Therapeutics annual EBITDA year-on-year change?
  • What is RAPT Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?
  • What is the all time high quarterly EBITDA for RAPT Therapeutics?
  • What is RAPT Therapeutics quarterly EBITDA year-on-year change?
  • What is RAPT Therapeutics TTM earnings before interest, taxes, depreciation & amortization?
  • What is the all time high TTM EBITDA for RAPT Therapeutics?
  • What is RAPT Therapeutics TTM EBITDA year-on-year change?

What is RAPT Therapeutics annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of RAPT is -$125.85 M

What is the all time high annual EBITDA for RAPT Therapeutics?

RAPT Therapeutics all-time high annual earnings before interest, taxes, depreciation & amortization is -$27.95 M

What is RAPT Therapeutics annual EBITDA year-on-year change?

Over the past year, RAPT annual earnings before interest, taxes, depreciation & amortization has changed by -$41.10 M (-48.49%)

What is RAPT Therapeutics quarterly earnings before interest, taxes, depreciation & amortization?

The current quarterly EBITDA of RAPT is -$19.49 M

What is the all time high quarterly EBITDA for RAPT Therapeutics?

RAPT Therapeutics all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$8.05 M

What is RAPT Therapeutics quarterly EBITDA year-on-year change?

Over the past year, RAPT quarterly earnings before interest, taxes, depreciation & amortization has changed by +$14.10 M (+41.98%)

What is RAPT Therapeutics TTM earnings before interest, taxes, depreciation & amortization?

The current TTM EBITDA of RAPT is -$113.61 M

What is the all time high TTM EBITDA for RAPT Therapeutics?

RAPT Therapeutics all-time high TTM earnings before interest, taxes, depreciation & amortization is -$8.05 M

What is RAPT Therapeutics TTM EBITDA year-on-year change?

Over the past year, RAPT TTM earnings before interest, taxes, depreciation & amortization has changed by +$3.52 M (+3.00%)